Gabapentin
- Product NDC
- 70518-3140
- 11-digit product format
- 705183140
- Labeler code
- 70518
- Product ID
- 70518-3140_c6749cde-de5d-b1f2-e053-2a95a90a7854
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA075477
- Marketing category
- ANDA
- Marketing start
- 2021-07-02
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3140-0 | 70518314000 | 30 CAPSULE in 1 BLISTER PACK (70518-3140-0) | 30 capsule | 2021-07-02 | 0000-00-00 | No | No | Current |